<TABLE>
FORM 4
|_| Check this box if no longer
subject to Section 16.
Form 4 or Form 5
obligations may continue.
See Instruction 1(b).
U.S. SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL
Washington, D.C. 20549 OMB Number 3525-0287
Expires: September 30, 1998
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Estimate average burden
hours per response: ...5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
<S> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2.Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person to Issuer
(Check all applicable)
Diacrin, Inc., Common Stock $.01 Par Value _X___Director __X__10% Owner
(Last) (First) (Middle) 3.IRS or Social Security 4.Statement for _____Officer ____Other
Number of Reporting Month/Year (give title below) (specify below)
Ruch Joshua Person (Voluntary)
March, 1998
(Street) 5.If Amendment, 7. Individual or Joint/Group Filing
Date of Original (check applicable line)
c/o Rho Management Company, Inc. 767 Fifth Avenue (Month/Year)
May, 1995 __X__ Form filed by One Reporting Person
(City) (State) (Zip)
Form filed by More than One Reporting Person
New York New York 10153
- ------------------------------------------------------------------------------------------------------------------------------------
Table I-- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of
(Instr. 3) action action or Disposed of (D) Securities ship Indirect
Date Code (Instr. 3, 4 and 5) Beneficially Form: Beneficial
(Month/ (Instr. 8) Owned at End Direct Ownership
Day/ of Month (D) or (Instr. 4)
Year) (Instr. 3 and 4) Indirect
(I)
(Instr. 4)
--------------------------------------------------------
Code V Amount (A) or Price
(D)
Diacrin, Inc. 1,612,887 I Via Rho
V Management
Partners, LP
Diacrin, Inc. V 54,500 D
- -----------------------------------------------------------------------------------------------------------------------------------
***
===================================================================================================================================
</TABLE>
* If the Form is filed by more than one Reporting Person, see Instruction
4(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
<PAGE>
<TABLE>
<S> <C> <C> <C> <C> <C> <C> <C>
(Print or Type Responses) FORM 4 (continued) Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
- -----------------------------------------------------------------------------------------------------------------------------------
1.Title of 2.Conver 3.Transac- 4.Transac- 5.Number of 6.Date Exer- 7.Title 8.Price of 9.Number of 10.Owner- 11. Nature of
Derivative sion or tion Date tion Code Derivative cisable and & Amount Derivative Deriva- ship form Indirect
Security Exercise (Month/ (Instr. 8) Securities Expiration of Under Security tive of Deriva Beneficial
(Instr.3) Price of Day/Year) Acquired (A) Date (Month lying Sec (Instr.5) Securities tive Sec Ownership
Deriv- or Disposal /Day/Year) urities Beneficially urity; (Instr.4)
ative (D)(Instr. 3, (Instr.3 Owned at End Direct(D)
Security 4, and 5) and 4) of Month or In-
(Instr.4) direct(I)
(Instr.4)
Date Expira- Amount or
Code V (A) (D) Exer- tion Title Number of
cisable Date Shares
Explanation of Responses:
/s/ Joshua Ruch March 26, 1998
** Signature of Reporting Person Date
</TABLE>
***Through limited partnership interests in HealthCare Ventures II, L.P., and
the HealthCare Partners II, L.P. and the HealthCare Ventures IV L.P., the
reporting person may also be deemed to have an indirect interest in the
approximately 646,000 shares of the Issuer owned by these limited Partnerships.
**Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
<PAGE>
